Elanco Animal Health’s Q2 Earnings Call Highlights

Elanco Animal Health ((ELAN)) has held its Q2 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ... Read More

Elanco reports pet parasite treatment quickly hit $100M blockbuster status

The sales momentum comes as Elanco prepares to open its $200 million-plus corporate campus next month on the west side of downtown Indianapolis. Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco posted Q2 sales of $1.24 billion, beating estimates and growing 5% YoY; adjusted EPS was $0.26, down 13% YoY. Pet Health revenue rose 11% to $643 million; Seresto and Advantage lines ... Read More

Demystifying Elanco Animal Health: Insights From 5 Analyst Reviews

During the last three months, 5 analysts shared their evaluations of Elanco Animal Health (NYSE:ELAN), revealing diverse outlooks from bullish to bearish. The following table provides a quick overview ... Read More

Elanco raises 2025 innovation revenue outlook to $720M–$800M, signals margin expansion through new launches

CEO Jeffrey N. Simmons highlighted, "Elanco continues to deliver, growing 8% organic constant currency in the quarter and exceeding the high end of guidance for revenue, adjusted EBITDA and adjusted ... Read More

Elanco Animal Health Incorporated (ELAN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Elanco Animal Health Incorporated ( NYSE: ELAN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 8:30 AM EDT Hi. Good morning, everyone. I'm Erin Wright, Healthcare Services ... Read More

Why Elanco (ELAN) Stock Is Trading Lower Today

What Happened? Shares of animal health company Elanco (NYSE:ELAN) fell 4.1% in the afternoon session after competitor Boehringer Ingelheim announced the U.S. launch of a new, advanced vaccine for ... Read More

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

NEW YORK, Aug. 26, 2025 /PRNewswire/ -- Elanco Animal Health Inc. (NYSE: ELAN) will replace Sarepta Therapeutics Inc. (NASD: SRPT) in the S&P MidCap 400, and Sarepta Therapeutics will replace ... Read More

State-owned chunk of former GM stamping plant site sold to Elanco for $27M

A rendering of Elanco Animal Health's new global headquarters in Indianapolis. (Courtesy Indiana Economic Development Corp.) The state of Indiana sold a chunk of a massive, long-vacant Indianapolis ... Read More

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per share of 26 cents, down 13% year over year. Despite the decline, earnings ... Read More